Publication | Closed Access

Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents

VaccinationVaccine SafetyVaccine DevelopmentPlacebo-controlled Phase 3Global HealthVirologyInterim ResultsVaccine EfficacyMedicineEndemic AreasCovid-19